(Q53650086)

English

A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis.

scientific article published in March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis. (English)

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

1 reference

based on heuristic

inferred from title

author name string

Kenar D Jhaveri

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

Carlos Flombaum

2

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

Manish Shah

3

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

Sheron Latcha

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

publication date

1 March 2012

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

Journal of Oncology Pharmacy Practice

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

18

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

140-147

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Population pharmacokinetic analysis of the major metabolites of capecitabine

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Complete and sustained remission of refractory cervical cancer following a single cycle of capecitabine. A case report

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy.

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients.

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Use of the MDRD study equation to estimate kidney function for drug dosing

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Effect of hemodialysis on the metabolic clearance of 5-Fluorouracil in a patient with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1177%2F1078155210390255

21 January 2018

Identifiers

10.1177/1078155210390255

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/22392964

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53650086&oldid=1570022112"